首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1935262

人工胰臟裝置系統（APDS）市場按技術、分銷管道和地區分類

Artificial Pancreas Device System (APDS) Market, By Technology, By Distribution Channel, By Geography

出版日期: 2026年01月16日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026 年人工胰臟設備系統市場規模預計為 4.876 億美元，預計到 2033 年將達到 16.342 億美元，2026 年至 2033 年的複合年成長率為 18.9%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	4.876億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	18.90%	2033 年的預測值：	16.342億美元

1型糖尿病患者每天需要多次注射胰島素。研究和技術進步促成了易於使用的胰島素輸注系統的商業化，包括胰島素筆、胰島素幫浦、吸入式胰島素和注射器。這些先進、易用的胰島素輸注系統的出現，使得傳統的注射器注射方式逐漸被淘汰。

此外，這些系統允許患者自行注射胰島素。人工胰臟系統能夠自動偵測患者血液或血漿中的葡萄糖水平，並據此調整所需的胰島素劑量。例如，Medtronic的MiniMed 670G就是一款穿戴式人工胰腺，它能夠自動監測葡萄糖水平，並透過連接到該裝置的胰島素幫浦輸注胰島素。人工胰臟技術包括發送器、感測器和胰島素幫浦。這使得對體內胰島素水平的持續監測成為可能，從而更便於糖尿病的管理。

市場動態

預計在預測期內，對新型人工胰腺裝置系統的持續研究和開發將支持人工胰腺裝置系統（APDS）市場的成長。

例如，2019 年 5 月，Beta Bionics 和 Zealand Pharma 開始對 iLet 仿生胰腺系統進行家庭試驗，該系統是一種雙激素泵系統，旨在根據連續血糖監測儀 (CGM) 的血糖值讀數自動施用胰島素和升糖素（Zealand Pharma 開發的一種在液態高血糖製劑）下穩定的實驗胰性高升糖素製劑）。

預計第 1 型糖尿病的高發生率將增加對新型監測系統的需求，這將推動人工胰臟裝置系統 (APDS) 市場在預測期內成長。

例如，根據世界衛生組織（WHO）的數據，全球糖尿病患者人數從1980年的1.08億增加到2014年的4.22億。此外，根據美國疾病管制與預防中心（CDC）的數據，第1型糖尿病約占美國成年人所有確診糖尿病病例的5%。

本次調查的主要特點

本報告對全球人工胰腺裝置系統 (APDS) 市場進行了詳細分析，並以 2025 年為基準年，給出了預測期 (2026-2033) 的市場規模和復合年成長率 (%)。
該報告還重點介紹了各個細分市場的潛在商機，並概述了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、區域前景以及主要企業採取的競爭策略的重要見解。
該研究根據以下參數對全球人工胰腺裝置系統 (APDS) 市場的主要企業進行了分析：公司概況、財務業績、產品系列、地理分佈、分銷策略、關鍵發展和策略以及未來計劃。
本報告的研究結果將使企業負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球人工胰臟裝置系統（APDS）市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種策略矩陣輕鬆做出決策，這些矩陣用於分析全球人工胰臟設備系統 (APDS) 市場。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
非洲
- 中非
- 南非
- 北非
中東
- GCC
- 以色列
- 其他中東國家

第7章競爭情勢

熱圖分析
公司簡介
- Medtronic Plc.
- Medtrum Technologies Inc.
- Tandem Diabetes Care, Inc.
- Johnson &Johnson
- Beta Bionics, Inc.
- Bigfoot Biomedical
- Insulet Corporation
- Pancreum, Inc.
- TypeZero Technologies, Inc.
- DreaMed Diabetes Ltd
- Inreda Diabetic BV

第8章各節

參考
調查方法

簡介目錄

Product Code: CMI79

Artificial Pancreas Device System Market is estimated to be valued at USD 487.60 Mn in 2026 and is expected to reach USD 1,634.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 487.60 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.90%	2033 Value Projection:	USD 1,634.2 Mn

Type 1 diabetes patients require multiple doses of insulin in a day. Advancements in research and technology has led to commercialization of easy-to-use insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems.

Moreover, these systems offer self-administration of insulin. Artificial pancreas system automatically detects glucose level in patient's blood or plasma, and accordingly administers necessary dosage of insulin. For instance, Medtronic's MiniMed 670G is one such wearable artificial pancreas that automatically monitors glucose levels, and delivers insulin through an insulin pump attached to the device. The artificial pancreas technology includes a transmitter, sensor, and insulin pump. This helps in continuous monitoring of insulin levels in body and manages diabetes at ease.

Market Dynamics

Continuous research and development of novel artificial pancreas device systems is expected to support the artificial pancreas device system (APDS) market growth over the forecast period.

For instance, in May 2019, Beta Bionics, Inc. and Zealand Pharma started an in-home trial of iLet Bionic Pancreas system, a dual-hormone pump system designed to automatically deliver insulin and dasiglucagon - an experimental form of glucagon designed by Zealand Pharma to be stable in liquid form- based on blood sugar readings from a continuous glucose monitor (CGM).

High prevalence of diabetes type 1 is expected to rise demand for its novel monitoring systems and drive the artificial pancreas device system (APDS) market growth over the forecast period.

For instance, according to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. Furthermore, according to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S.

Key features of the study

This report provides in-depth analysis of global artificial pancreas device system (APDS) market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026 - 2033), considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global artificial pancreas device system (APDS) market based on following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global artificial pancreas device system (APDS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global artificial pancreas device system (APDS) market

Market Segmentation

By Technology
- Threshold Suspended Device Systems
- Treat to Range/Control to Range (TTR/CTR)
- Treat to Target/ Control to Target (TTR/CTT)
By Distribution Channel
- Hospitals & Clinics
- Retail Channel
- Online Channel
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Artificial Pancreas Device System Market Companies
- Medtronic Plc.
- Medtrum Technologies Inc.
- Tandem Diabetes Care, Inc.
- Johnson & Johnson
- Beta Bionics, Inc.
- Bigfoot Biomedical
- Insulet Corporation
- Pancreum, Inc.
- TypeZero Technologies, Inc.
- DreaMed Diabetes Ltd
- Inreda Diabetic BV

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Restraints
Market Opportunities
Impact Analysis
Technology Assessment
Reimbursement
Regulatory Scenario
Product Launch/Approval
Merger and Acquisitions/Collaborations
Product Pipeline Analysis
Pricing Analysis
PEST Analysis

4. Global Artificial Pancreas Device System (APDS) Market, By Technology, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Threshold Suspended Device Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Treat to Range/Control to Range (TTR/CTR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Treat to Target/ Control to Target (TTR/CTT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Retail Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Artificial Pancreas Device System (APDS) Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
North America
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033 (USD Mn)
  - Central Africa
  - South Africa
  - North Africa
Middle East
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East

7. Competitive Landscape

Heat Map Analysis
Company Profiles
- Medtronic Plc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Medtrum Technologies Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Tandem Diabetes Care, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Beta Bionics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bigfoot Biomedical
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Insulet Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pancreum, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- TypeZero Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- DreaMed Diabetes Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Inreda Diabetic BV
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies